September 21, 2026

Becton, Dickinson and Company (BDX) Stock Analysis: Balancing Dividend Yield and Growth Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a formidable..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 6.22% Dividend Yield Amidst Healthcare Sector Shifts

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor interest with its robust 6.22% dividend yield, positioning itself as a potentially..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Market with Strong Buy Ratings and Robust Revenue Growth

As a leading player in the healthcare sector, Thermo Fisher Scientific Inc. (NYSE: TMO) stands at the forefront of the diagnostics and research industry. With a..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 17.6% Potential Upside and Strong Revenue Growth

With a rich history dating back to its founding in 1781, Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a global powerhouse in the healthcare sector,..

Sanofi (SNY) Stock Analysis: Exploring a 26.46% Upside Potential in the Healthcare Sector

Sanofi (NASDAQ: SNY), a titan in the healthcare sector, has caught the attention of investors with its substantial market cap of $101.79 billion and a compelling..

Investor Outlook: Edwards Lifesciences (EW) Sees 14.39% Upside with Strong Buy Ratings

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector with a market capitalization of $50.82 billion, is making waves in the healthcare industry...

argenx SE (ARGX) Stock Analysis: Exploring a Promising 19.21% Potential Upside

Investors seeking exposure to the biotech sector might find argenx SE (ARGX) an intriguing opportunity. Based in the Netherlands, this commercial-stage biopharma company is making significant..

Elevance Health, Inc. (ELV) Stock Analysis: Insights into a Healthcare Giant with Nearly 10% Upside Potential

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare plans industry, boasting a market capitalization of $89.12 billion. As a health benefits..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Giant with an 8% Upside Potential

Danaher Corporation (NYSE: DHR), a formidable player in the healthcare sector specializing in diagnostics and research, stands out with its robust market capitalization of $148.9 billion...

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Revenue Growth and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) has long been a titan in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Foster City, California, Gilead..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 34% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, stands as a compelling consideration..

CVS Health Corporation (CVS) Stock Analysis: Unlocking a 30.89% Upside Potential in Healthcare

As CVS Health Corporation (NYSE: CVS) continues to solidify its presence in the healthcare sector, individual investors are presented with an interesting opportunity to explore a..

Amgen Inc. (AMGN) Stock Analysis: Navigating Growth with a Robust Pipeline and a 2.61% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture the attention of investors with its robust portfolio of therapeutics and promising financial..

Abbott Laboratories (ABT) Stock Analysis: Robust Growth and a 17% Upside Potential Beckon Investors

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its impressive market cap of $178.73 billion and a robust..

Novartis AG (NVS) Investor Outlook: Evaluating the 11.53% Potential Upside and Robust Dividend Yield

Novartis AG (NYSE: NVS), a powerhouse in the healthcare sector, operates within the global pharmaceutical landscape. With its market capitalization standing at an impressive $266.8 billion,..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 42.5% Upside Potential for Investors

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector specializing in medical devices, offers a compelling investment case with a significant upside potential..

Johnson & Johnson (JNJ) Stock Analysis: Navigating through Healthcare with a Robust Growth and Dividend Outlook

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its expansive market cap of $650.65 billion. As a..

Global property capital shifts towards quality as European retail regains attention

Global real estate activity is recovering, with capital increasingly targeting high-quality assets and European retail properties supported by strong locations, limited supply and changing consumer demand...

AstraZeneca’s Klygefa recommended for EU approval in generalised myasthenia gravis

The EMA’s CHMP has recommended Klygefa (gefurulimab) for approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase III PREVAIL..
Search

Funds

September 21, 2026

Global property capital shifts towards quality as European retail regains attention

Global real estate activity is recovering, with capital increasingly targeting high-quality assets and European retail properties supported by strong locations, limited supply and changing consumer demand...

AstraZeneca’s Klygefa recommended for EU approval in generalised myasthenia gravis

The EMA’s CHMP has recommended Klygefa (gefurulimab) for approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase III PREVAIL trial results...
Search

Funds

September 21, 2026

FTSE 100

Funds